Pien Huang
Stories
-
Health
Why remdesivir, a highly effective treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for Covid patients. But the drug is relatively expensive and hard to administer, relegating it what some are calling "stopgap" status.
-
National
Remdesivir can help COVID patients avoid the hospital. But it's been slow to catch on
The antiviral infusion Remdesivir was just revived as an early treatment for COVID. It can be expensive and hard to administer, but is useful when monoclonals and pills are in short supply like now.
-
Health
Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised
So far the government has distributed about 300,000 doses of Evusheld, a new drug that protects against COVID-19. Some 7 million Americans could benefit from the drug right away.
-
Health
A drug that helps immunocompromised people fight COVID is in short supply
Antibody-based drug Evusheld protects immune-suppressed people against COVID-19 for up to six months. The drug is hard to get, and some hospitals are selecting patients by lottery.
-
Politics
A year in, experts assess Biden's hits and misses on handling the pandemic
When he came into office, Biden launched an ambitious seven-point plan for defeating the virus. Here's how experts score his results.
-
National
Advisers to the CDC say kids as young as 12 should get COVID booster shots
Advisers to the Centers for Disease Control and Prevention say kids as young as 12 should get booster shots. This endorsement clears the way for the CDC to approve boosters for kids between 12 and 15.
-
National
The CDC says a test to get out of COVID isolation is not needed, resisting pushback
Those who contracted COVID-19 can end their isolation after five days while continuing to wear a well-fitting mask for an additional five days, according to the agency.
-
Health
New CDC isolation guidelines raise concerns among health experts
Cutting the isolation for positive cases to five days could lead to more infections if people don't take masking seriously. A testing requirement, would have made the policy safer, experts say.
-
Health
Pfizer has announced new results for a pill that fights COVID-19
Pfizer's analysis shows that the drug is good at keeping people at high risk of COVID-19 from getting worse. The pill is called Paxlovid.
-
Health
New antiviral drugs are coming for COVID. Here's what you need to know
The FDA is considering new pills that could treat people in early stages of COVID. Here's what to know about how they work, how effective they are and the impact they could make on the pandemic.